Infertility (Testing & Treatment) Market by Male Infertility (Testing & Treatment Types) Market by Female Infertility (Hysterosalpingography, Laparoscopy, Transvaginal, Ultrasound, Ovarian Reserve Testing, Hormone Tests & Female Infertility Treatment Types) by Key Analytic & Region Forecast 2016-2024.
Global infertility (testing & treatment) market is poised to grow during 2016-2022. Various reasons for the growth of the fertilization market are increasing infertility across the world, delayed pregnancies, growing social acceptance of fertilization techniques, improving healthcare infrastructure and more awareness. WHO estimated that almost 25% couples in developing countries are infertile. There is a growing rate of infertility all over the globe. Reasons for infertility are increasing late marriages leading to higher maternal age, gynecological issues, growing incidences of obesity and addiction to alcohol, smoking, and tobacco.
Global infertility (testing & treatment) market forecast 2016-2022 is segmented on the basis of geography, testing, transfer techniques, procedure and end users. In developing countries, the prevalence is variable, it is as high as 30 percent in Sub-Saharan Africa to as low as 5 percent in China. One of the major reasons for increasing number of infertility cases is the changing lifestyle in developed countries. Delayed pregnancies are one of the major causes for increasing infertility rate. However, in certain cases causes of infertility are congenital. The demand for infertility treatment has increased in developed economies due to decreasing reproduction capabilities. To maintain the current population growth an average rate 2.1 children per female are required.
Browse Complete Report with TOC @ https://www.inkwoodresearch.com/reports/global-infertility-testing-treatment-market-forecast-2016-2024/
Infertility treatment is a multi-billion dollar industry, which was valued at $18 billion in 2015. The key factors driving the market include rising awareness among couples about various infertility treatments, aggressive focus on healthcare infrastructure specifically in terms of infertility treatments in developing economies, low-cost treatment options and an increase in new options for infertility treatment such as surrogacy. Medical tourism has been a key enabler for the growth in the infertility treatment market.
In vitro fertilization (IVF) methods contribute the largest percentage of revenues (73.26) to the overall treatment market. The treatment segment includes pre-cycles cost, which involves testing and diagnostic methods. IVF also includes costs for drug and hormonal therapy used during the process to onset ovulation and aid in successful fertilization. Factors that will restrain market growth are high costs associated with the procedure, low awareness in developing economies like Africa, ethical considerations and insufficient reimbursement policies for IVF treatment.
Market regions that are covered in the report are North America, Europe, Asia-Pacific, and RoW. Europe and North America has the largest market share of fertilization market. It pioneered the IVF technique and continuous research and development and investment has led to constant market growth. Standardization of procedures through automation, regulatory reforms and government funding for egg/sperm storage are the contributing factors for growth of the market in North America.
The Asia-Pacific market is expected to report the highest growth in the years 2016-2022. Increasing awareness, higher cases of infertility, more disposable income along with the rise in lifestyle diseases will be the market drivers for the growth of In-vitro fertilization market in Asia Pacific region. Technological advancements are being adopted in various countries like China, Japan and India and this too will boost the market growth of In-vitro fertilization. Japan has the largest market share in Asia Pacific.
The major market players for fertilization are Vitrolife AB, EMD Serono Inc., Irvine Scientific, Cooper Surgical Inc., Cook Medical Inc., Thermo Fisher Scientific Inc., Genea Biomedx, Boston IVF, Progyny Inc. and Ovascience. Companies are forming alliances and are going for mergers and acquisitions to strengthen their market position. Organizations are investing in research and development to come up with novel and innovative products that will capture new market share.
Browse Healthcare Reports of Inkwood Research @ https://www.inkwoodresearch.com/reports/category/healthcare/